statins and glp-1 Slash (Human Trial) – 44 Second Summary, Human trial data published in a major journal show that statins cause insulin resistance deplete GLP-1 levels in humans. This should have Why Foundayo, the new once-daily

Beyond its metabolic functions, GLP-1 is involved in regulating various behaviors, including feeding, fluid intake, and even motivated behaviors like drug consumption

(The recommendation is not the same as FDA approval.) Heres my recent Peptide Curious deep dive

Scavenging ROS with N-acetylcysteine inhibits insulin secretion by decreasing ROS (Figure 6A)

Dosage and Administration: Dosage: Inject 3mL per 100kg body weight (15mL per 500kg horse) by intramuscular injection twice weekly or as directed by a veterinarian

At this stage, GLP-1 medications cannot be viewed as treatments for endometriosis

Based on these observations with GEP12, and on our unexpected findings that GEP44-mediated increases in ISR and decreases in glucagon release can be detected only in the presence of Y1-R antagonists, we proceeded to characterize the contributions of Y1-R to glucose uptake in muscle tissue